SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-20-000072
Filing Date
2020-02-11
Accepted
2020-02-11 16:14:31
Documents
1
Group Members
JEFFREY K. VOGEL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A biospecifics_13ga1.htm SC 13G/A 70071
  Complete submission text file 0001019056-20-000072.txt   71302
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 20596775
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEADOW DRIVE LAWRENCE NY 11559
Business Address
Vogel Jeffrey Kenneth (Filed by) CIK: 0001348315 (see all company filings)

Type: SC 13G/A